CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 186 filers reported holding CHEMOCENTRYX INC in Q1 2021. The put-call ratio across all filers is 1.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $922,000 | +108.6% | 17,848 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $442,000 | -1.1% | 17,848 | +0.1% | 0.00% | 0.0% |
| Q1 2022 | $447,000 | -31.1% | 17,828 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $649,000 | +112.8% | 17,828 | -0.0% | 0.00% | 0.0% |
| Q3 2021 | $305,000 | +27.6% | 17,829 | 0.0% | 0.00% | – |
| Q2 2021 | $239,000 | -72.1% | 17,829 | +6.7% | 0.00% | -100.0% |
| Q1 2021 | $857,000 | -14.1% | 16,717 | +3.7% | 0.00% | 0.0% |
| Q4 2020 | $998,000 | +13.2% | 16,117 | +0.1% | 0.00% | 0.0% |
| Q3 2020 | $882,000 | -1.1% | 16,097 | +3.9% | 0.00% | 0.0% |
| Q2 2020 | $892,000 | +47.9% | 15,497 | +3.2% | 0.00% | 0.0% |
| Q1 2020 | $603,000 | +26.4% | 15,013 | +24.6% | 0.00% | +100.0% |
| Q4 2019 | $477,000 | +488.9% | 12,053 | +1.4% | 0.00% | – |
| Q3 2019 | $81,000 | -27.0% | 11,883 | 0.0% | 0.00% | – |
| Q2 2019 | $111,000 | – | 11,883 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 436,300 | $15,886,000 | 6.25% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $18,205,000 | 3.66% |
| Integral Health Asset Management, LLC | 200,000 | $7,282,000 | 2.02% |
| Sofinnova Investments, Inc. | 731,222 | $26,624,000 | 1.56% |
| Lisanti Capital Growth, LLC | 231,035 | $8,412,000 | 1.22% |
| Darwin Global Management, Ltd. | 161,802 | $5,891,000 | 0.90% |
| Cormorant Asset Management, LP | 400,000 | $14,564,000 | 0.87% |
| Perceptive Advisors | 2,830,892 | $103,072,000 | 0.80% |
| Avidity Partners Management LP | 644,400 | $23,463,000 | 0.50% |
| Eventide Asset Management | 1,040,000 | $37,866,000 | 0.48% |